Boston Hospital Launches First Human Trial of Nasal Vaccine for Alzheimer s Disease Everyday Health MenuNewslettersSearch Alzheimer's Disease News Boston Hospital Launches First Human Trial of Nasal Vaccine for Alzheimer s DiseaseResearchers hope vaccine could offer a safe and effective way to prevent or slow down progression of AD. By Becky UphamNovember 19, 2021Fact-CheckedThe vaccine uses the immune modulator Protollin, an intranasal agent that’s made of proteins derived from bacteria.Andrew Brookes/Getty ImagesBrigham and Women’s Hospital in Boston is set to begin a clinical trial that will test the safety and efficacy of a new vaccine delivered nasally that has been developed to prevent and slow the progression of Alzheimer’s disease (AD). The launch is a remarkable milestone, said Howard L. Weiner, MD, codirector of the Ann Romney Center for Neurologic Diseases at the Brigham, in a press release. “Over the last two decades, we’ve amassed preclinical evidence suggesting the potential of this nasal vaccine for AD. If clinical trials in humans show that the vaccine is safe and effective, this could represent a nontoxic treatment for people with Alzheimer’s, and it could also be given early to help prevent Alzheimer’s in people at risk,” he said. An estimated 55 million people live with dementia, which is a general term for impaired ability to remember, think or make decisions beyond what might be expected from the usual consequences of growing old, according to the World Health Organization (WHO). Alzheimer’s disease is the most common form of dementia, and may account for 60 to 70 percent of cases. Vaccine Designed to Trigger an Immune Response to Fight Disease Process The vaccine uses the immune modulator Protollin, an intranasal agent that’s made of proteins derived from bacteria and has been used safely in humans as an adjuvant for other vaccines. An adjuvant is an ingredient used to make vaccines work better by creating a stronger immune response, according to the Centers for Disease Control and Prevention (CDC). According to researchers, Protollin is designed to activate white blood cells found in the lymph nodes on the sides and back of the neck to go to the brain and trigger clearance of beta amyloid plaques which is one of the hallmarks of AD, according to researchers. In the brain of someone with Alzheimer’s, there are abnormal levels of the protein amyloid that clump together and form plaques. These collect between neurons and disrupt cell function, according to the National Institute on Aging. Many experts believe that reducing amyloids would reduce memory loss and cognitive decline. Phase 1 Trial Will Test the Safety and Tolerability of Vaccine The trial contains 16 participants between 60 and 85 years of age with early, symptomatic AD. All the participants are in good general health with no disease expected to interfere with the study and have had an amyloid-positive PET scan. Each of the subjects will get two doses of the nasal vaccine, with the second dose being delivered a week after the first. This trial’s primary objective is to find out if the vaccine is safe and well tolerated, and the impact of nasal Protollin on participants’ immune response, including its effects on white blood cells, will also be measured. “This vaccine goes to show the immune system is important for so many things outside of infection, such as neurological diseases, cancers, heart disease, and the list goes on,” says Purvi Parikh, MD, a clinical assistant professor at NYU Grossman School of Medicine and immunologist at NYU Langone, both in New York City. Dr. Parikh is not involved in the clinical trial. “It’s exciting that we can train our immune system with vaccines to fight these disease in an effective way,” she says. NEWSLETTERS Sign up for our Healthy Living Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy. The Latest in Alzheimer' s Disease Experimental Alzheimer s Drug Slows Cognitive Decline in Large Study Drugmakers Biogen and Eisai reported that their experimental drug lecanemab worked for people with mild cognitive impairment or mild Alzheimer’s disease...By Lisa RapaportSeptember 30, 2022 2 Hispanic Americans Speak Out About Dementia in Their CommunitiesTony Gonzales and Myra Solano Garcia are using their personal and professional talents to raise awareness of dementia among Hispanic Americans, even while...By Brian P. DunleavySeptember 29, 2022 Flu Vaccine Tied to Lower Alzheimer s Disease RiskOlder adults who get flu vaccinations are less apt to develop Alzheimer’s disease than their counterparts who don’t, a study suggests.By Lisa RapaportJune 29, 2022 Brain Scan Can Aid Early Detection of Alzheimer s DiseaseMachine learning technology can read MRI scans to identify Alzheimer’s disease in the earliest stages when it’s easier to treat, a new study suggests....By Lisa RapaportJune 24, 2022 Medicare Limits Coverage of Alzheimer s Drug Aduhelm to People in Clinical TrialsThe unprecedented decision by the agency creates unnecessary barriers for patients and may discourage future AD research, say advocacy groups.By Becky UphamApril 15, 2022 Some Early Warning Signs of Alzheimer s May Show Up in Your ThirtiesYounger adults with high levels of sugars and fats in their blood have an increased risk of developing Alzheimer’s disease decades later, a study suggests...By Lisa RapaportApril 8, 2022 Viagra May Significantly Cut Alzheimer s Risk Study FindsA popular prescription medication shows potential as a treatment for dementia.By Don RaufDecember 9, 2021 Food Rx Two Neurologists Share What They Eat in Hopes of Heading Off Alzheimer s DiseaseWhile no diet is proven to prevent Alzheimer’s, this pair of married doctors is placing their bets on a whole-food, plant-based diet.By Barbara KeanNovember 18, 2021 Alzheimer s Awareness Month Campaign Encourages Families to Confront Cognitive ConcernsIf dementia is diagnosed early on, a person can get the maximum benefit from available treatments. But fewer than half of Americans polled say they would...By Don RaufNovember 5, 2021 Poetry and a Positive Attitude Help Eugenia Zukerman Get on With Life With Alzheimer s DiseaseBy Eugenia ZukermanOctober 27, 2021See AllMORE IN HPV Vaccine Offers Cancer and Genital Wart Prevention How to Stop the COVID-19 Pandemic Inside the Vaccine Clinical Trials The Johnson & Johnson COVID-19 Vaccine What You Need to Know